[2008 Standards, Options: recommendations for venous thromboembolic events (VTE) treatment and central venous catheter thrombosis (CVCT) management in cancer patients].
暂无分享,去创建一个
H. Lévesque | G. Meyer | P. Mismetti | A. Elias | I. Quéré | I. Mahé | J. Renaudin | G. Le Gal | D. Farge-Bancel | I. Elalamy | H. Desmurs-Clavel | P. Debourdeau | M. Pavic | C. Grange | F. Cajfinger | M. Scrobohaci | L. Bosquet | D. Kassab-Chahmi | H. Hocini | E. Desruennes | M. Douard | I. Kriegel | Diana Kassab-Chahmi
[1] Sonal Singh,et al. Thromboprophylaxis in cancer patients with central venous catheters , 2007, Thrombosis and Haemostasis.
[2] P. Wells,et al. Thromboprophylaxis for catheter‐related thrombosis in patients with cancer: a systematic review of the randomized, controlled trials , 2007, Journal of thrombosis and haemostasis : JTH.
[3] G. Raskob,et al. Prevention of central venous catheter-associated thrombosis: a meta-analysis. , 2007, The American journal of medicine.
[4] C. Newburn-Cook,et al. The use of low-dose warfarin as prophylaxis for central venous catheter thrombosis in patients with cancer: a meta-analysis. , 2007, Oncology nursing forum.
[5] H. Büller,et al. Prevention of catheter‐related venous thrombosis with nadroparin in patients receiving chemotherapy for hematologic malignancies: a randomized, placebo‐controlled study , 2007, Journal of thrombosis and haemostasis : JTH.
[6] D. Cook,et al. Anticoagulation for thrombosis prophylaxis in cancer patients with central venous catheters. , 2007, The Cochrane database of systematic reviews.
[7] Russell D Hull,et al. Long-term low-molecular-weight heparin versus usual care in proximal-vein thrombosis patients with cancer. , 2006, The American journal of medicine.
[8] M. Mandalà,et al. Is recurrent venous thromboembolism after therapy reduced by low-molecular-weight heparin compared with oral anticoagulants? , 2006, Chest.
[9] Jawed Fareed,et al. Secondary Prevention of Venous Thromboembolic Events in Patients With Active Cancer: Enoxaparin Alone Versus Initial Enoxaparin Followed by Warfarin for a 180-Day Period , 2006, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.
[10] F. Wesenberg,et al. Low‐dose warfarin for the prevention of central line‐associated thromboses in children with malignancies—a randomized, controlled study , 2006, Acta paediatrica.
[11] U. Waheed,et al. Inferior Vena Cava Filter Placement in Late-Stage Cancer , 2006, Vascular and endovascular surgery.
[12] M. De Cicco,et al. Short-term acenocumarine (A) or dalteparine (D) for the prevention of central venous catheter-related thrombosis (CVCrT) in cancer patients. A randomized controlled study based on serial venographies. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[13] M. Levine,et al. Incidence, risk factors, and outcomes of catheter-related thrombosis in adult patients with cancer. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[14] I. Finlay,et al. Acceptability of low molecular weight heparin thromboprophylaxis for inpatients receiving palliative care: qualitative study , 2006, BMJ : British Medical Journal.
[15] G. Steger,et al. Dalteparin for prevention of catheter-related complications in cancer patients with central venous catheters: final results of a double-blind, placebo-controlled phase III trial. , 2006, Annals of oncology : official journal of the European Society for Medical Oncology.
[16] B. White,et al. Primary thromboprophylaxis for cancer patients with central venous catheters – a reappraisal of the evidence , 2006, British Journal of Cancer.
[17] L. Castagna,et al. High incidence of INR alteration in gastrointestinal cancer patients treated with mini-dose warfarin and 5-fluorouracil-based regimens. , 2006, Annals of oncology : official journal of the European Society for Medical Oncology.
[18] A. Zerati,et al. Vena cava filters in cancer patients: experience with 50 patients. , 2005, Clinics.
[19] S. Laporte,et al. Enoxaparin in the treatment of deep vein thrombosis with or without pulmonary embolism: an individual patient data meta-analysis. , 2005, Chest.
[20] D. Anderson,et al. Randomized placebo-controlled study of low-dose warfarin for the prevention of central venous catheter-associated thrombosis in patients with cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[21] Armando Santoro,et al. Enoxaparin for the prevention of venous thromboembolism associated with central vein catheter: a double-blind, placebo-controlled, randomized study in cancer patients. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[22] D. Kerr,et al. WARP - A multicentre prospective randomised controlled trial (RCT) of thrombosis prophylaxis with warfarin in cancer patients with central venous catheters (CVCs) , 2005 .
[23] B. Asselain,et al. Thrombose symptomatique sur cathéter veineux central de longue durée en oncologie : un score de risque prédictif? , 2005 .
[24] I. Finlay,et al. Is long-term low-molecular-weight heparin acceptable to palliative care patients in the treatment of cancer related venous thromboembolism? A qualitative study , 2005, Palliative medicine.
[25] M. Prins,et al. Randomized comparison of low molecular weight heparin and coumarin derivatives on the survival of patients with cancer and venous thromboembolism. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[26] Vincent Vinh-Hung,et al. Catheter tip position as a risk factor for thrombosis associated with the use of subcutaneous infusion ports , 2005, Supportive Care in Cancer.
[27] J. Kuhn,et al. A prospective randomized trial demonstrating valved implantable ports have fewer complications and lower overall cost than nonvalved implantable ports. , 2004, American journal of surgery.
[28] K. Ahrar,et al. Use of inferior vena caval filters and survival in patients with malignancy , 2004, Cancer.
[29] Clifford W Colwell,et al. Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. , 2004, Chest.
[30] T. Ben Othman,et al. Prevention of central venous line-related thrombosis by continuous infusion of low-dose unfractionated heparin, in patients with haemato-oncological disease , 2004, Thrombosis and Haemostasis.
[31] A. Maubon,et al. Thrombotic complications of implanted central venous access devices: prospective evaluation. , 2004, Bulletin du cancer.
[32] J. Eikelboom,et al. Low-molecular-weight heparin compared with intravenous unfractionated heparin for treatment of pulmonary embolism: a meta-analysis of randomized, controlled trials. , 2004, Annals of internal medicine.
[33] A. D. Van den Abbeele,et al. The Treatment and Outcome of Cancer Patients with Thromboses on Central Venous Catheters , 2000, Journal of Thrombosis and Thrombolysis.
[34] R. Sundaram,et al. To clot or not to clot? That is the question in central venous catheters. , 2004, Clinical radiology.
[35] Susanne M. Smorenburg,et al. Thrombosis prophylaxis in patient populations with a central venous catheter: a systematic review. , 2003, Archives of internal medicine.
[36] A. Iorio,et al. Low‐molecular‐weight heparin for the long‐term treatment of symptomatic venous thromboembolism: meta‐analysis of the randomized comparisons with oral anticoagulants , 2003, Journal of thrombosis and haemostasis : JTH.
[37] L. Castagna,et al. Minidose warfarin is associated with a high incidence of International Normalized Ratio elevation during chemotherapy with FOLFOX regimen. , 2003, Annals of Oncology.
[38] A. Santoro,et al. Minidose warfarin prophylaxis for catheter-associated thrombosis in cancer patients: can it be safely associated with fluorouracil-based chemotherapy? , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[39] G. Feder,et al. Development and validation of an international appraisal instrument for assessing the quality of clinical practice guidelines: the AGREE project , 2003, Quality & safety in health care.
[40] S. Laporte,et al. Low-molecular-weight heparin (nadroparin) and very low doses of warfarin in the prevention of upper extremity thrombosis in cancer patients with indwelling long-term central venous catheters: a pilot randomized trial. , 2003, Haematologica.
[41] Paolo Prandoni,et al. Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis. , 2002, Blood.
[42] K. Calligaro,et al. Inferior vena cava filters in malignant disease. , 2002, Journal of vascular surgery.
[43] J. Dichgans,et al. Low molecular weight heparin for deep vein thrombosis in glioma patients , 2002, Journal of Neurology.
[44] N. Vučić,et al. Treatment of deep vein thrombosis with oral anticoagulants in patients with malignancy: prospective cohort study. , 2002, Croatian medical journal.
[45] D. Heaton,et al. Minidose (1 mg) warfarin as prophylaxis for central vein catheter thrombosis , 2002, Internal medicine journal.
[46] P. Vardas,et al. PROPHYLAXIS WITH UROKINASE IN PEDIATRIC ONCOLOGY PATIENTS WITH CENTRAL VENOUS CATHETERS , 2002, Pediatric hematology and oncology.
[47] Yves Gruel,et al. Comparison of low-molecular-weight heparin and warfarin for the secondary prevention of venous thromboembolism in patients with cancer: a randomized controlled study. , 2002, Archives of internal medicine.
[48] A. Luciani,et al. Catheter-related upper extremity deep venous thrombosis in cancer patients: a prospective study based on Doppler US. , 2002, Radiology.
[49] F. Orsi,et al. A randomized, prospective trial of central venous ports connected to standard open‐ended or Groshong catheters in adult oncology patients , 2001, Cancer.
[50] A. Kakkar,et al. Thromboembolism in brain tumors , 2001, Current opinion in pulmonary medicine.
[51] J. Renaud-salis,et al. SOR: project methodology , 2001, British Journal of Cancer.
[52] J. Hirsh,et al. A Comparison of the Safety and Efficacy of Oral Antiocoagulation for the Treatment of Venous Thromboembolic Disease in Patients with or without Malignancy , 2000, Thrombosis and Haemostasis.
[53] D. Wallace,et al. Warfarin is safe as secondary prophylaxis in patients with cancer and a previous episode of venous thrombosis. , 2000, American journal of clinical oncology.
[54] J. Douketis,et al. A meta-analysis comparing low-molecular-weight heparins with unfractionated heparin in the treatment of venous thromboembolism: examining some unanswered questions regarding location of treatment, product type, and dosing frequency. , 2000, Archives of internal medicine.
[55] M. Martínez-González,et al. Do the low molecular weight heparins improve efficacy and safety of the treatment of deep venous thrombosis? A meta-analysis. , 2000, Haematologica.
[56] K. Savage,et al. Outpatient Use of Low Molecular Weight Heparin (Dalteparin) for the Treatment of Deep Vein Thrombosis of the Upper Extremity , 1999, Thrombosis and Haemostasis.
[57] R. Bona,et al. Regional Thrombolysis with Urokinase for Central Venous Catheter-related Thrombosis in Patients Undergoing High-dose Chemotherapy with Autologous Blood Stem Cell Rescue , 1999, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.
[58] M. Gould,et al. Low-molecular-weight heparins compared with unfractionated heparin for treatment of acute deep venous thrombosis. A meta-analysis of randomized, controlled trials. , 1999, Annals of internal medicine.
[59] S. Berman,et al. Treatment of patients with venous thromboembolism and malignant disease: should vena cava filter placement be routine? , 1998, Journal of vascular surgery.
[60] M. Prins,et al. Low molecular weight heparin versus unfractionated heparin in the initial treatment of venous thromboembolism. , 1998, Current opinion in pulmonary medicine.
[61] F. Grodstein,et al. Attenuation over 24 hours of the efficacy of thrombolysis of pulmonary embolism among patients with cancer. , 1997, American heart journal.
[62] L. Greenfield,et al. Clinical Results of Greenfield Filter Use in Patients with Cancer , 1997, Cardiovascular surgery.
[63] A. Norman,et al. A prospective analysis of 949 long-term central venous access catheters for ambulatory chemotherapy in patients with gastrointestinal malignancy. , 1997, European journal of cancer.
[64] B. Leduc,et al. Fibrinolyse des thromboses veineuses profondes sur dispositifs de perfusion implantables. A propos d'une série consécutive de 57 thromboses et de 32 fibrinolyses. , 1996 .
[65] D. Farge,et al. Traitement anticoagulant classique de la maladie thromboembolique veineuse chez les patients cancéreux. A propos d'une série rétrospective de 71 patients , 1996 .
[66] J. Hirsh,et al. Low-molecular-weight heparins and unfractionated heparin in the treatment of patients with acute venous thromboembolism: results of a meta-analysis. , 1996, The American journal of medicine.
[67] P. Craft,et al. Hickman catheters: left-sided insertion, male gender, and obesity are associated with an increased risk of complications. , 1996, Australian and New Zealand journal of medicine.
[68] R. Rosell,et al. Upper Extremity Deep Venous Thrombosis in Cancer Patients with Venous Access Devices - Prophylaxis with a Low Molecular Weight Heparin (Fragmin) , 1996, Thrombosis and Haemostasis.
[69] M. Burt,et al. Inferior vena cava filters in cancer patients: indications and outcome. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[70] M. Prins,et al. Treatment of deep venous thrombosis with low-molecular-weight heparins. A meta-analysis. , 1995, Archives of internal medicine.
[71] J. Renaud-salis,et al. Methodologie de developpement des standards, options et recommandations diagnostiques et therapeutiques en cancerologie , 1995 .
[72] B. Eastridge,et al. Complications of indwelling venous access devices in cancer patients. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[73] J. Abbruzzese,et al. The Bird's Nest Filter: An Alternative to Long‐Term Oral Anticoagulation in Patients with Advanced Malignancies , 1994, American journal of clinical oncology.
[74] J. O'fallon,et al. Thromboembolism in patients with high-grade glioma. , 1994, Mayo Clinic proceedings.
[75] L. Deangelis,et al. Therapy of venous thromboembolism in patients with brain metastases , 1994, Cancer.
[76] R. Hellman,et al. Venous Thromboembolism and High Grade Gliomas , 1993, Thrombosis and Haemostasis.
[77] P. Wen,et al. Complications of therapy for venous thromboembolic disease in patients with brain tumors , 1993, Neurology.
[78] S. Rodenhuis,et al. Central venous catheter associated thrombosis of major veins: thrombolytic treatment with recombinant tissue plasminogen activator. , 1993, Thorax.
[79] M. Citron,et al. Greenfield filter instead of heparin as primary treatment for deep venous thrombosis or pulmonary embolism in patients with cancer , 1992, Cancer.
[80] R. Woodruff,et al. Complications and failure of anticoagulation therapy in the treatment of venous thromboembolism in patients with disseminated malignancy. , 1992, Australian and New Zealand journal of medicine.
[81] J. Ensley,et al. The Incidence and significance of thromboembolic complications in patients with high‐grade gliomas , 1991, Cancer.
[82] K. Calligaro,et al. Thromboembolic complications in patients with advanced cancer: Anticoagulation versus greenfield filter placement , 1991, Annals of vascular surgery.
[83] M. Citron,et al. Greenfield filter as primary therapy for deep venous thrombosis and/or pulmonary embolism in patients with cancer. , 1991, Surgery.
[84] E. Altschuler,et al. The risk and efficacy of anticoagulant therapy in the treatment of thromboembolic complications in patients with primary malignant brain tumors. , 1990, Neurosurgery.
[85] P. Benotti,et al. Very low doses of warfarin can prevent thrombosis in central venous catheters. A randomized prospective trial. , 1990, Annals of internal medicine.
[86] R. Ruff,et al. Incidence and treatment of peripheral venous thrombosis in patients with glioma , 1983, Annals of neurology.
[87] J. Hankinson,et al. Incidence of lower extremity deep vein thrombosis in neurosurgical patients. , 1980, Neurosurgery.